Search results
Mirum (MIRM) Rises More Than 30% in Past 3 Months: Here's Why
Zacks via Yahoo Singapore Finance· 6 days agoThe recent label expansion of Mirum's (MIRM) lead drug, Livmarli, is expected to drive sales in the...
Column: Pharmacy middlemen claim to keep prescription prices low. In fact, they've cost consumers...
LA Times via Yahoo News Singapore· 3 days agoMagnify the gains on those two drugs by the potential profits the PBMs may be extracting from the...